Cash for cancer trials: does reimbursement reduce financial toxicity?

NCT ID NCT05871125

Completed Symptom relief Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving monthly reimbursements to women with breast cancer in clinical trials could reduce their financial hardship. Thirty-nine participants received payments for trial-related expenses, and researchers tracked how many completed the study and surveys. The goal was to see if this approach is feasible and helps ease money worries during treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: monthly reimbursement payments
What this could lead to: If successful, this approach could help reduce financial stress for cancer patients in clinical trials, making participation more manageable.
What could go wrong: This was a small, early-stage study with only 39 participants, so results may not apply to all patients or settings. It focused on feasibility, not effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.